JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...
The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, ...
BNB Plus Corp. ("BNBX" or the "Company"), today announced that it has received a $1.2M USD order for LineaDNA, representing the largest LineaDNA order in Company history. The order is an acceleration ...
Strong PALSONIFY U.S. Launch Execution Resulted in Unaudited and Preliminary Net Product Revenue of >$5 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December ...
JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 ...
Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated technical report (the "Report") for the updated Feasibility Study ("FS" or "Study"), prepared in ...
REITs are positioned for multi-year outperformance, with accelerating AFFO growth, healthy balance sheets, and discounted ...
TORONTO, ON / ACCESS Newswire / January 5, 2026 / Churchill Resources Inc. ("Churchill" or the "Company") (TSXV:CRI.V) is ...
First 2026 cyber recap covering IoT exploits, wallet breaches, malicious extensions, phishing, malware, and early AI abuse.
VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ -- (TSX: LUC) (BSE: LUC) (Nasdaq First North: LUC) Lucara Diamond Corp. ("Lucara" or the "Company") is pleased to announce the results of an updated ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
Milan and Madrid are the top performers. Defense stocks and banks are dominating. Big Tech is sprinting on Wall Street, but Tesla ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results